Lance Wilkes
Stock Analyst at Bernstein
(1.81)
# 2,040
Out of 4,479 analysts
15
Total ratings
77.78%
Success rate
15.62%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare | Downgrades: Market Perform | $301 | $319.70 | -5.85% | 3 | Jan 4, 2024 | |
| CI Cigna | Upgrades: Outperform | $372 | $325.91 | +14.14% | 4 | Jan 4, 2024 | |
| HUM Humana | Maintains: Market Perform | $568 → $599 | $374.82 | +59.81% | 2 | Aug 8, 2023 | |
| UNH UnitedHealth Group | Upgrades: Outperform | $595 → $603 | $498.24 | +21.03% | 3 | Jul 18, 2023 | |
| CVS CVS Health | Maintains: Market Perform | $107 → $93 | $57.52 | +61.68% | 2 | May 2, 2023 | |
| CNC Centene | Reinstates: Outperform | $108 | $66.19 | +63.17% | 1 | May 27, 2022 |
HCA Healthcare
Jan 4, 2024
Downgrades: Market Perform
Price Target: $301
Current: $319.70
Upside: -5.85%
Cigna
Jan 4, 2024
Upgrades: Outperform
Price Target: $372
Current: $325.91
Upside: +14.14%
Humana
Aug 8, 2023
Maintains: Market Perform
Price Target: $568 → $599
Current: $374.82
Upside: +59.81%
UnitedHealth Group
Jul 18, 2023
Upgrades: Outperform
Price Target: $595 → $603
Current: $498.24
Upside: +21.03%
CVS Health
May 2, 2023
Maintains: Market Perform
Price Target: $107 → $93
Current: $57.52
Upside: +61.68%
Centene
May 27, 2022
Reinstates: Outperform
Price Target: $108
Current: $66.19
Upside: +63.17%